Jordan R E
Arch Biochem Biophys. 1983 Dec;227(2):587-95. doi: 10.1016/0003-9861(83)90488-5.
Heparin is thought to regulate the rate of mammalian blood clotting by enhancing the activity of antithrombin, an inhibitor of coagulation enzymes. The present study establishes that this same inhibitor is present in the blood plasma of each of the terrestrial vertebrate groups including mammals, birds, reptiles, and amphibians. In each case, an inhibitor with remarkably similar properties to human antithrombin was isolated by affinity chromatography on immobilized porcine heparin. The purified vertebrate inhibitors all show the following physical and functional homologies to human antithrombin: (i) heparin-enhanced inhibition of both bovine thrombin and human Factor Xa, (ii) molecular masses of approximately 60,000, and (iii) heparin-induced increases in ultraviolet fluorescence. Also, the heparin-binding interaction of vertebrate antithrombins is highly selective with each demonstrating the same rigid specificity for heparin species fractionated on the basis of their affinity for human antithrombin. This common ability of vertebrate antithrombins to discriminate among heparins is accomplished by a nearly unvarying equilibrium binding constant for the high-affinity heparin species. Thus, the present results suggest that the anticoagulant relationship of heparin and antithrombin was established at an early point in the evolution of the coagulation system and has been highly conserved since that time.
肝素被认为是通过增强抗凝血酶(一种凝血酶抑制剂)的活性来调节哺乳动物的血液凝固速率。本研究证实,包括哺乳动物、鸟类、爬行动物和两栖动物在内的每一类陆生脊椎动物的血浆中都存在这种相同的抑制剂。在每种情况下,通过固定化猪肝素亲和层析法分离出了与人类抗凝血酶性质极为相似的抑制剂。纯化后的脊椎动物抑制剂在以下物理和功能方面均与人类抗凝血酶具有同源性:(i)肝素增强对牛凝血酶和人因子Xa的抑制作用;(ii)分子量约为60,000;(iii)肝素诱导紫外线荧光增强。此外,脊椎动物抗凝血酶与肝素的结合相互作用具有高度选择性,每种抗凝血酶对基于其对人类抗凝血酶的亲和力分级的肝素种类都表现出相同的严格特异性。脊椎动物抗凝血酶区分肝素的这种共同能力是通过高亲和力肝素种类几乎不变的平衡结合常数实现的。因此,目前的结果表明,肝素与抗凝血酶的抗凝血关系在凝血系统进化的早期就已确立,自那时起一直高度保守。